Navigate the AI era with confidence. TCS helps you turn AI into a strategic partner that empowers talent, reimagines processes, and accelerates business transformation.
We deliver excellence and create value for customers and communities - everyday. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
Learn how AI agents transform pharmacovigilance from a compliance function into an intelligence engine, unlocking enterprise value across the product lifecycle.
Choose the right generative AI architecture in pharma by comparing LLM with RAG, SPM, and hybrid with routing to protect critical data sovereignty. Explore how.
TCS biostatistics and statistical programming (BSP) services provide expert data analysis and statistical analysis for clinical trial data insights. Learn more.
Sovereign cloud enables industries to innovate at scale and ensure data protection and sovereignty and regulatory compliance across digital ecosystems.
TCS and Tata Chemicals leveraged Microsoft Azure to transform manufacturing plant maintenance with generative AI, driving faster repairs and better productivity.
Accelerate responsible enterprise AI adoption and secure AI governance with TCS Engage for Microsoft Copilot, driving strategic business value realization.
Solution
28 Oct 2026
Join us at the Life Sciences Forum at TCS Pace Port™, New York
Generative AI (GenAI) technologies have tremendous potential across the life sciences value chain. These technologies can improve health outcomes and quality of life—from accelerated drug discovery and faster, efficient clinical trials to autonomous manufacturing and improved sales and marketing.
The recently published TCS AI for Business Study brings forth the following interesting insights:
44% of the life sciences companies agreed to use AI to create new revenue streams
51% of executives want to build enterprise-specific large language models (LLMs) for GenAI implementations
58% of industry leaders favor an enterprise strategy for AI and want to experiment and take risks with AI
The potential of GenAI for the life sciences industry is promising. We invite you to discuss the vast potential of GenAI and challenges posed by regulated industries such as life sciences and technology and skill limitations that impede scale, and the collective way forward.
Join our keynote speaker and an eminent industry expert at the life sciences forum to discover how practitioners can adopt an AI-first mindset to build a next-gen enterprise. Gain insights on how to:
Reimagine knowledge work and skills with AI augmentation to push the frontiers of enterprise performance
Build an elite-by-design enterprise with a focus on high quality, consistency, and productivity
Develop a secure, reliable, and resilient AI fabric with Responsible AI 2.0
Keynote speaker
Sankaranarayanan Viswanathan, Vice President and Head of Business Innovation, Chief Technology Office, TCS
